<!DOCTYPE html>
<html lang="en">
<head>
<title>openMetaAnalysis: methods</title>
<meta name="author" content="openMetaAnalysis Contributors">
<meta name="viewport" content="width=device-width, initial-scale=1.0">
<meta http-equiv="Content-Type" content="text/html; charset=UTF-8" />

<!-- jquery -->
<script src="//ajax.googleapis.com/ajax/libs/jquery/2.1.1/jquery.js"></script>
<script src="/openmetaanalysis.js"></script>
<script>
$(document).ready(function(){
  //button handlers
  $(".type2").on("click", function(){
  	if ($("#iqr").is(':checked')){
  		$("#subjects").css("background-color",lightgray);
  		}
	else{
  		$("#subjects").css("background-color",white);
  		}
  });
  $("#bttncalculate").on("click", function(e){
    e.preventDefault();
	var subjects = parseFloat($("#denom1").val())  + parseFloat($("#denom2").val()) ;
	if ($("#counts").is(':checked')){
		weightedvalue = 100*((parseFloat($("#numer1").val()) + parseFloat($("#numer2").val()))/subjects);
		//weightedvalue = (($("#numer1").val()*$("#denom1").val() + $("#numer2").val()*$("#denom2").val())/subjects);
		weightedvalue = weightedvalue.toFixed(2).toString() + "%";
		}
	if ($("#percents").is(':checked')){
		weightedvalue = (($("#numer1").val()*$("#denom1").val() + $("#numer2").val()*$("#denom2").val())/subjects);
		weightedvalue = weightedvalue.toFixed(2).toString() + "%";
		}
	if ($("#means").is(':checked')){
		weightedvalue = (($("#numer1").val()*$("#denom1").val() + $("#numer2").val()*$("#denom2").val())/subjects);
		weightedvalue = weightedvalue.toFixed(2).toString();
		}
    $("#answer").html(weightedvalue);
  });
  $("#bttncalculate2").on("click", function(e){
    e.preventDefault();
	var width = Math.abs(parseFloat($("#upper").val()) - parseFloat($("#lower").val()) );
	var se = 0;
	var sd = 0;
	var subjects = parseFloat($("#subjects").val());
	if ($("#ci").is(':checked')){
		se = width/2/1.96 //Chinn, 2000 PMID 11113947
		sd = se * Math.sqrt(subjects)  //Varies with sample size
		}
	if ($("#iqr").is(':checked')){
		sd = width/1.35;
		}
	if ($("#range").is(':checked')){
		sd = width/4;
		}
	if ($("#median").val() != ''){
		median = parseFloat($("#median").val())
		if ($("#median").val() != '' && $("#range").is(':checked')){
			// Hozo, 2005 PMID 15840177: equation 4
			var mean = (parseFloat($("#lower").val()) + 2*median + parseFloat($("#upper").val()) )/4 + (parseFloat($("#lower").val()) - 2*median + parseFloat($("#upper").val()) )/(4*subjects)
			mean = mean.toFixed(2).toString();
			$("#answer_mean").html(mean);
			}
		else if ($("#median").val() != '' && $("#iqr").is(':checked')){
			// Wan, 2014 PMID 25524443: equation 14
			var mean = (parseFloat($("#lower").val()) + median + parseFloat($("#upper").val()) )/3
			mean = mean.toFixed(2).toString();
			$("#answer_mean").html(mean);
			}
		else	{
			alert('Selecte Range and enter values for the range in order to convert the median to a mean.')
			}
		}
	sd = sd.toFixed(2).toString();
    	$("#answer_sd").html(sd);
  });
  $("#bttncalculate3").on("click", function(e){
  //Continous to binary conversion
    e.preventDefault();
	var width = Math.abs(parseFloat($("#upper3").val()) - parseFloat($("#lower3").val()) );
	var or = 1;
	var se = 0;
	var subjects = parseFloat($("#subjects3").val());
	se = width/2/1.96 //Chinn, 2000 PMID 11113947
	sd = se * Math.sqrt(subjects)  //Varies with sample size
	smd = parseFloat($("#meandiff3").val()) / sd;
	or = Math.exp(1.81 * smd)
	sebin = Math.exp(1.81 * se)
    	$("#answer3").html(or.toFixed(2).toString() + "(" + (or-1.96*sebin).toFixed(2).toString() + " to " + (or+1.96*sebin).toFixed(2).toString() + ")");
  });
});
</script>
<style>
.wrapper
{
  width: 860px;
  margin-top: 0px;
  margin-right: auto;
  margin-bottom: 0px;
  margin-left: auto;
}

table, td, th{
 padding:10px;
 border: 1px solid black;
 border-collapse: collapse;
}

/* Menu from http://codepen.io/philhoyt/pen/ujHzd */
#primary_nav_wrap
{
	margin-top:15px;
}

#primary_nav_wrap ul
{
	list-style:none;
	position:relative;
	float:left;
	margin:0;
	padding:0
}

#primary_nav_wrap ul a
{
	display:block;
	background-color:#6DC6E7;
	color:#FFFFFF;
	text-decoration:none;
	font-weight:bold;
	//font-weight:700;
	//font-size:12px;
	line-height:32px;
	padding:0 15px;
	//font-family:"HelveticaNeue","Helvetica Neue",Helvetica,Arial,sans-serif
}

#primary_nav_wrap ul li
{
	position:relative;
	float:left;
	margin:0;
	padding:0
}

#primary_nav_wrap ul li.current-menu-item
{
	background:#0022B4;
		color:#FFFFFF;
}

#primary_nav_wrap ul a:hover
{
	background:#0022B4;
	color:#FFFFFF;
}

#primary_nav_wrap ul ul
{
	display:none;
	position:absolute;
	top:100%;
	left:0;
	background-color:#6DC6E7;
	color:#FFFFFF;
	padding:0
}

#primary_nav_wrap ul ul li
{
	float:none;
	width:200px
}

#primary_nav_wrap ul ul a
{
	line-height:120%;
	padding:10px 15px;
}

#primary_nav_wrap ul ul ul
{
	top:0;
	left:100%
}

#primary_nav_wrap ul li:hover > ul
{
	display:block
}
</style>
</head>

<body>
<!-- 
http://jquery-csv.googlecode.com/git/examples/basic-usage.html
http://jquery-csv.googlecode.com/git/examples/flot.html -> seems best and most stable without reticulating spines error
http://code.google.com/p/jquery-csv/wiki/API -> instructions
-->
<div class="wrapper">

<div class="page-header">
      <div style="color:#0022B4">
		<h1>openMetaAnalysis: <span style="font-size:50%">collaborative and continuous</span></h1>
	</div>

<nav id="primary_nav_wrap">
<ul id="menu">
<li class="listitem"><a href="http://openmetaanalysis.github.io/" class="menuitem">Home</a></li>
<li class="listitem"><a href="#" class="menuitem">Editors</a>
	<ul>
	<li><a href="opencpu-launch.htm?https://openmetaanalysis.ocpu.io/home/www/editor.html" class="menuitem">Intervention</a></li>
	<li><a href="opencpu-launch.htm?https://openmetaanalysis.ocpu.io/home/www/editor.html#instruct" class="menuitem">Intervention (instructional)</a></li>
	<li><a href="opencpu-launch.htm?https://openmetaanalysis.ocpu.io/home/www/editor-dx.html" class="menuitem">Diagnosis</a></li>
	<li class="listitem"><a href="https://openmetaanalysis.ocpu.io/home/www/arrows.html" class="menuitem">Arrows Plot</a></li>
	</ul>
</li>
<li class="listitem"><a href="http://openmetaanalysis.github.io/methods.html" class="menuitem">Methods</a></li>
<li class="listitem"><a href="http://openmetaanalysis.github.io/new.html" class="menuitem">Create a new review</a></li>
<li class="listitem"><a href="http://openmetaanalysis.github.io/update.html" class="menuitem">Improve/update an existing review</a></li>
</ul>
</nav>
</div>
<div style="clear:both">&nbsp;</div>

	<h1 style="color:#0022B4">Methods</h1>

<div>Methods are adapted from:</div>
<ul>
<li><a href="http://handbook-5-1.cochrane.org/">Cochrane Handbook</a></li>
<li><a href="http://www.gradeworkinggroup.org/">GRADE Working Group</a>. openMetaAnalysis, similar to meta-analysis in general, focuses on the intial 4 - 6 steps of the GRADE process (see Box 1 at <a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC428525/">BMJ, 2006</a>).</li>
<li><a href="http://www.bris.ac.uk/quadas/quadas-2/">QUADAS-2</a> (for meta-analyses of diagnostic tests)</li>
<li><a href="http://www.prisma-statement.org/">PRISMA</a> Statement (PMID: <a href="http://pubmed.gov/19622512">19622512</a>) and Checklist. PRISMA items 7 - 11 are substantially affected by using open and continuous updating.</li>
</ul>

<div>Contents:</div>
<ul>
<li><a href="#study_selection">Selecton of studies</a></li>
<li><a href="#searching">Searching for studies</a></li>
<li><a href="#data_abstraction">Data abstraction</a> (including data imputing)</li>
<li><a href="#quality_of_studies">Assessing quality of individual studies</a></li>
<li><a href="#analysis">Statistical analysis</a></li>
<li><a href="#quality_of_group_of_studies">Assessing quality across a group of studies</a></li>
<li><a href="#sof">Summary of Findings</a></li>
<li><a href="#reconciliation_tables">Reconciliation tables</a></li>
</ul>

<div>
<a name="study_selection"/>
<span style="font-weight:bold;font-size:130%">Selecton of studies</span>
<span style="font-weight:bold"> (PRISMA Item 6)</span>
</div>
<p>Meta-analysis of randomized controlled trials:</p>
<ul>
<li>Random allocation</li>
</ul>

<p>Meta-analysis of diagnostic test accuracy:</p>
<ul>
<li>Cross sectional or cohort design (not case controls)</li>
<li>Random or consecutive selection of patients</li>
<li>All patients received a reference standard</li>
</ul>
<div>More strict criteria for inclusion may be based on the <a href="https://acpjc.acponline.org/shared/purpose_and_procedure.htm">criteria by American College of Physicians Journal Club (ACPJC)</a>.</div>
<div>&nbsp;</div>
<div>We encourage reviews to have a Table of Reconciliation of Studies (<a href="https://github.com/openmetaanalysis/Early-goal-directed-therapy-for-septic-shock/tree/master/reconciliation%20of%20studies/">example</a>) that tabulates studies included by prior reviews and their status in the living review (Not part of PRISMA checklist). The has been advocated previously (PMID <a href="http://pubmed.gov25551377">25551377</a>).
<div>&nbsp;</div>
<div>
<a name="searching"/>
<span style="font-weight:bold;font-size:130%">Searching for studies</span>
<span style="font-weight:bold"> (PRISMA Items 7,8)</span>
</div>
<p>1. Start with making a reconciliation table of all studies included in at least one recent meta-analysis. (PMID <a href="https://pubmed.gov/27136216">27136216</a>)</p>
	<ul>
		<li>Identify up to 3-4 recent meta-analyses; place these in the columns a a table</li>
		<li>List each trial in the rows of a spreadsheet.</li>
		<li>In each cell, note whether a study was included or the reason it was not</li>
		<li><a href="https://github.com/openMetaAnalysis/Early-goal-directed-therapy-for-septic-shock/tree/master/reconciliation-tables">Example of reconciliation tables</a></li>
	</ul>
	
<p>2. Search for more recent studies with traditional searching using search terms</p>
	<ul>
		<li>Search PubMed with a 'Brief Search Strategy'(PMID <a href="http://pubmed.gov/16042789">16042789</a>)</li>
		<li>Manual searches of online textbooks</li>
		<li>For clinical trials
			<ul>
				<li>Search of the <a href="http://www.cochranelibrary.com/">Cochrane Central Register of Controlled Trials (CENTRAL)</a></li>
				<li>Clinical Trials registries with methods suggested by Glanville (<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4076126/">PMC4076126</a>):
					<ul>
					<li><a href="https://clinicaltrials.gov/ct2/search/advanced">ClinicalTrials.gov</a> (for studies with completed results and the search term random*)</li>
					<li><a href="http://apps.who.int/trialsearch/AdvSearch.aspx">International Clinical Trials Registry Platform (ICTRP)</a> (WHO)</li>
					</ul>
				</li>
			</ul>
		</li>
	</ul>
<p>3. Search for more recent studies with <a href="#" class="hastip" id="cited_references">cited reference searches</a></p>
	<ul>
		<li>Identify the seminal (most highly cite)d meta-analysis and original study by using <a href="http://scholar.google.com">Google Scholar</a> or <a href="http://isiknowledge.com">Web of Science</a> to retrieve the number of citations to each study on the reconciliaiton table. This work can be reduced by starting with studies in high impact journals. <a href="https://github.com/openMetaAnalysis/Procalcitonin-guided-antibiotics-for-severe-sepsis-and-septic-shock/issues/18">Example</a></li>
		<li>Execute cited references searches with these studies alysis using <a href="http://scholar.google.com">Google Scholar</a> or <a href="http://isiknowledge.com">Web of Science</a> to retrieve the number of citations to each study on the reconciliaiton table. This work can be reduced by starting with studies in high impact journals.</li>
	</ul>
<p>4. Each time a study is identified at PubMed, look for addiitonal studies using <a href="http://www.ncbi.nlm.nih.gov/books/NBK3827/#pubmedhelp.Finding_articles_rel">PubMed's Find Related Data portlet</a></p>

<p>If you find qualifying studies to an existing repository at openMetaAnalysis</p>
	<ul>
		<li>Please add the citation to the relevant: 1) data table, 2) PICO table, and 3) risk of bias table.</li>
		<li>Update the relevant forest plot</li>
		<li><i>Consider publishing the updated meta-analysis in a journal.</i></li>
	</ul>

<div>
<a name="data_abstraction"/>
<span style="font-weight:bold;font-size:130%">Data abstraction</span>

<span style="font-weight:bold"> (PRISMA Items 9-11)</span>
</div>
<table style="border-style:none;border: none;">
<tr><td>
<div>Creating the files for PICO and Bias tables</div>
<ul>
	<li><a href="http://openmetaanalysis.github.io/make-table-pico.html">http://openmetaanalysis.github.io/make-table-pico.html</a> will help make the content for the PICO tables.</li>
	<li><a href="http://openmetaanalysis.github.io/make-table-bias.html">http://openmetaanalysis.github.io/make-table-bias.html</a> will help make the content for the Risk of bias table.</li>
</ul>
<div>Consider using an online collaborative text editor with a colleague to develop the xml files for the PICO and bias tables.</div>
<ul>
	<li><a href="https://kobra.io">Kobra</a> is very easy to use. Kobra itself is collaboratively developed with <a href="http://www.firepad.io">Firepad</a>.</li>
</ul>
</td>
<td>
<form>
	<table>
		<caption>Calculation of population characteristics from 'Table 1' of studies for PICO Table in openMetaAnalysis</caption>
		<tr><th>Group 1</th><th>Group 2</th></tr>
		<tr><td><input type="text" id="numer1" placeholder="Proportion or mean"/></td><td><input type="text" id="numer2" placeholder="Proportion or mean"/></td></tr>
		<tr><td><input type="text" id="denom1" placeholder="Number of subjects"/></td><td><input type="text" id="denom2" placeholder="Number of subjects"/></td></tr>
		<tr><td colspan="2" align="center"><input id="counts" name="type" type="radio"><label for="counts">Counts</label>&nbsp;<input id="percents" name="type" type="radio"><label for="percents">Percentages</label>&nbsp;<input id="means" name="type" type="radio"><label for="means">Means</label>&nbsp;</td></tr>
		<tr><td colspan="2"><button id="bttncalculate">Calculate weighted value</button> Weighted value: <span id="answer"></span></td></tr>
	</table>
</form>
<form>
	<table>
		<caption>Calculation of standard deviation from<br/>confidence interval, range, or interquartile range</caption>
		<tr><td><input type="text" id="lower" placeholder="Lower limit"/></td><td><input type="text" id="median" placeholder="Median (optional)"/></td><td><input type="text" id="upper" placeholder="Upper limit"/></td></tr>
		<tr><td colspan="3" align="center"><input type="text" id="subjects" placeholder="Number subjects in group" style="width: 200px;" /></td></tr>
		<tr><td colspan="3" align="center"><input id="ci" name="type2" class="type2" type="radio"><label for="ci">Confidence interval</label>&nbsp;<input id="iqr" name="type2" class="type2" type="radio"><label for="iqr">Interquartile range</label>&nbsp;<input id="range" name="type2" class="type3" type="radio"><label for="range">Range</label></td></tr>
		<tr><td colspan="3"><button id="bttncalculate2">Calculate standard deviation</button> Mean: <span id="answer_mean"></span> SD: <span id="answer_sd"></span>
			<div>Details from: <a href="http://pubmed.gov/25524443,15840177">mean to median</a>, <a href="http://pubmed.gov/11113947">confidence interval</a>, <a href="http://handbook-5-1.cochrane.org/chapter_7/7_7_3_5_mediansand_interquartile_ranges.htm">interquartile range</a>, and <a href="http://www.biomedcentral.com/1471-2288/5/13">range</a>. See downloadable spreadsheet for calculations by Wan, 2014 PMID <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4383202/">25524443</a></div>
		</td></tr>
	</table>
</form>
<form>
	<table>
		<caption>Converting continuous measures into binary measures</caption>
		<tr><td colspan="2">Many calculators for data conversions are at <a href="http://www.campbellcollaboration.org/escalc/html/EffectSizeCalculator-SMD1.php">George Mason University</a>. Equations for conversion <a href="http://handbook-5-1.cochrane.org/chapter_9/9_4_6_combining_dichotomous_and_continuous_outcomes.htm">are available</a> at the Cochrane handbook-5-1.</tr>
		<tr><td colspan="2" align="center"><input onclick="alert('Not implemented')" id="twosamples3" name="type2" class="type2" type="radio"><label for="twosamples3">Two group means</label>&nbsp;<input id="smd3" name="type2" class="type2" type="radio"><label for="smd3">Single difference between group means</label></td></tr>
		<tr class="onedifference3"><td><input type="text" id="lower3" placeholder="CI lower limit"/></td><td><div></div><input type="text" id="upper3" placeholder="CI upper limit"/></td></tr>
		<tr class="onedifference3"><td colspan="2" align="center"><input type="text" id="subjects3" placeholder="Number subjects in group" style="width: 200px;" />
			<div><input type="text" id="meandiff3" placeholder="Mean difference" style="width: 200px;" /></div>
		</td></tr>
		<tr><td colspan="2"><button id="bttncalculate3">Calculate binary measures</button> Odds ratio (under construction): <span id="answer3"></span>
			<div>Details from: Chinn, 2000 (PMID <a href="http://pubmed.gov/11113947">11113947</a>) and da Costa, 2014 (PMID <a href="http://pubmed.gov/23045205">23045205</a>).</div>
		</td></tr>
	</table>
</form>
</td></tr>
</table>

<a name="SMD"/>
<div><a href="http://handbook-5-1.cochrane.org/chapter_9/9_2_3_2_the_standardized_mean_difference.htm">Standardized mean differences</a> may be abstracted. One proposed interpretration of the SMD is: (PMID <a href="http://pubmed.gov/19565683">19565683</a>)</div>
<ul>
	<li>0.2 represents a small effect</li>    
	<li>0.5 a moderate effect</li>
	<li>0.8 a large effect</li>
</ul>

<div>
<a name="quality_of_studies"/>
<span style="font-weight:bold;font-size:130%">Assessing quality of individual studies</span>
<span style="font-weight:bold"> (PRISMA Items 12)</span>
</div>

		<div><a href="https://robot-reviewer.vortext.systems/">Robot Reviewer</a> can help you locate text in articles to make determinations of biases.</div>
<ul>
<li>Studies of intervention
	<ul>
	<li><a href="http://handbook-5-1.cochrane.org/chapter_8/table_8_5_d_criteria_for_judging_risk_of_bias_in_the_risk_of.htm">Individual criteria for judging risk of bias</a> in a trial using the '<a href="http://handbook-5-1.cochrane.org/chapter_8/8_5_the_cochrane_collaborations_tool_for_assessing_risk_of_bias.htm">Cochrane's Risk of bias tool</a>'.(1)
		<ul>
			<li>Attrition: consider judgment of 'Unclear risk" it no Consort flow diagram</li>
			<li>Selective reporting: consider judgment of 'Unclear risk" it no access to original protocol at a online trial registry</li>
		</ul>		
	</li>
	<li><a href="http://handbook-5-1.cochrane.org/chapter_8/table_8_7_a_possible_approach_for_summary_assessments_of_the.htm">Aggregating individual criteria into a summary judgment about a trial</a> (see column "Within a study")</li>
	</ul>
</li>
<li>Studies of diagnostic accuracy
	<ul>
	<li><a href="http://www.bris.ac.uk/quadas/quadas-2/">Four criteria for judging risk of bias from QUADAS-2</a> (see Risk of bias row in the Table guided by the detailed criteria in the rows above)</li>
	</ul>
</li>
<li>Studies of prognosis and risk factors
	<ul>
	<li>Cochrane's <a href="http://methods.cochrane.org/sites/methods.cochrane.org.prognosis/files/public/uploads/QUIPS tool.pdf">Quality In Prognosis Studies (QUIP) tool</a> (PMID <a href="https://pubmed.gov/23420236">23420236</a>)</li>
	</ul>
</li>
<li>Conflict of interest
<ul>
	<li><a Href="http://www.icmje.org/recommendations/browse/roles-and-responsibilities/author-responsibilities--conflicts-of-interest.html">Per ICJME</a>, "Authors should avoid entering in to agreements with study sponsors, both for-profit and nonprofit,
that interfere with authors’ access to all of the study’s data or that interfere with their ability to analyze and interpret the data and to prepare and publish manuscripts
independently when and where they choose.". Thus, adding to selective reporting or publication bias if authors without conflicts did not vouch for the data. However, disclosure on conflicts of interest bu authors may not be complete (<a href="http://pubmed.gov/25835490">25835490</a></li>
</ul></li>
</ul>

<div>
<a name="analysis"/>
<span style="font-weight:bold;font-size:130%">Statistical analysis</span>
<span style="font-weight:bold"> (PRISMA Items 13 - 16)</span>
</div>

<p>Analyses are done with online at <a href="https://www.opencpu.org/">OpenCPU</a> using <a href="http://cran.r-project.org/">R</a>. Editors are available for <a href="https://openmetaanalysis.ocpu.io/home/www/editor.html">randomized controlled trials</a> and <a href="https://openmetaanalysis.ocpu.io/home/www/editor-dx.html">diagnostic tests accuracy studies</a>.</p>
<ul>
<li>Studies of intervention
	<ul>
	<li>We use the random effects model with the inverse variance as implemented in the R package <a href="http://cran.r-project.org/web/packages/meta/">meta</a>.</li>
	<li>The Knapp-Hartung method adjusts test statistics and confidence intervals to gives wider (more conservative) confidence intervals and is one of the methods suggested by Cornell et al.(PMID <a href="http://pubmed.gov/24727843">24727843</a>)</li>
	<li>The continuity correction of Diamond is used.(PMID: <a href="http://pubmed.gov/17679700">17679700</a>)</li>
	<li>Summary measures for binary outcomes include odds ratio and relative risk. Measures for continuous outcomes are either mean differences or <a href="http://handbook-5-1.cochrane.org/chapter_12/12_6_interpreting_results_from_continuous_outcomes_including.htm" class="hastip" id="smd_definition">standardized mean differences</a>.</li>
	<li>Subgroup analyses and meta-regressions are done as needed with the R package <a href="http://cran.r-project.org/web/packages/meta/">meta</a>. This includes investigating correlation of the control rate with the outcome
		<ul><li><a href="http://pubmed.gov/24339017,21908417,15358396,9777687?dopt=abstract">PubMed citations</a></li></ul>
	</li>
	<li>Heterogeneity is assessed with I<sup>2</sup> (4)</li>
	</ul>
</li>
<li>Studies of diagnosis
	<ul>
	<li>Hierarchial bivariate model (Reitsma, 2005. PMID <a href="http://pubmed.gov/16168343">16168343</a>) as implemented in the R package <a href="http://cran.r-project.org/web/packages/Metatron/">metatron</a> with AUC from the R package <a href="http://cran.r-project.org/web/packages/mada/">mada</a></li>
	</ul>
</li>
</ul>

<div>
<a name="quality_of_group_of_studies"/>
<a id="user-content-assessing-quality-of-a-group-of-studies" class="anchor" href="#assessing-quality-of-a-group-of-studies" aria-hidden="true"><span class="octicon octicon-link"></span></a>
<span style="font-weight:bold;font-size:130%">Assessing quality across a group of studies</span>
<span style="font-weight:bold"> (PRISMA Items 15)</span>
</div>

<p><a href="http://handbook-5-1.cochrane.org/chapter_12/table_12_2_b_factors_that_may_decrease_the_quality_level_of_a.htm">Factors</a> developed by the <a href="http://www.gradeworkinggroup.org/">GRADE Working Group</a> are below for assessing a group of studies in a meta-analysis (PMID <a href="http://pubmed.gov/22542023">22542023</a>). (2) Specific criteria for each factor are are based on those used by the <a href="http://back.cochrane.org/">Cochrane Back Group</a> with modifications noted below.(PMID: <a href="http://pubmed.gov/23362516">23362516</a>)</p>

<table>
<tbody>
<tr style="background-color:lightgray">
<th>Factors</th>
<th>Criteria</th>
</tr>
<tr>
<td>Limitations in the design and implementation of available studies</td>
<td>&bull; Serious risk of bias: More than 25% of participants from studies with low methodological quality as measured by the Cochrane's (interventions) or QUADAS-2 (diagnostic tests) Risk of bias tool (see above)<br>&bull; Very serious risk of bias: More than 50% of participants from studies with low methodological quality as measured by the Cochrane's (interventions) or QUADAS-2 (diagnostic tests) Risk of bias tool</td>
</tr>
<tr>
<td>Indirectness</td>
<td>&nbsp;</td>
</tr>
<tr>
<td>Heterogeneity or inconsistency of results<br>(modified from the Cochrane Back Group)</td>
<td>&bull; Serious heterogeneity: &gt;=75% of participants from studies with findings in the same direction or I<sup>2</sup> &gt;= 30%.(30% to 60% may represent moderate heterogeneity per <a href="http://handbook-5-1.cochrane.org/chapter_9/9_5_2_identifying_and_measuring_heterogeneity.htm">Identifying and measuring heterogeneity</a>)<br>&bull; Very serious heterogeneity: I<sup>2</sup> &gt;= 60% as 50% to 90%: may represent substantial heterogeneity.(3)</td>
</tr>
<tr>
<td>Imprecision of results<br>(modified from the Cochrane Back Group)</td>
<td>&bull; Serious imprecision: Fewer than 2000 participants for each outcome (PMID: <a href="http://pubmed.gov/11158556">11158556</a>) or confidence intervals that include clinically unimportant outcomes<br>&bull; Very serious imprecision: Fewer than 300 participants for each outcome.(PMID: <a href="http://pubmed.gov/23362516">23362516</a>)
<div>An alternative approach to determining imprecision is to use the "optimal information size" (PMID: <a href="http://pubmed.gov/21839614">21839614</a>) with an online calculator (<a href="http://www.stat.ubc.ca/~rollin/stats/ssize/b2.html">http://www.stat.ubc.ca/~rollin/stats/ssize/b2.html</a>).</div>	
</td>
</tr>
<tr>
<td>Probability of publication bias</td>
<td>This area of meta-analytic practice is evolving and presently only addresses studies of interventions. See discussion at <a href="http://handbook-5-1.cochrane.org/chapter_10/10_4_5_summary.htm">http://handbook-5-1.cochrane.org/chapter_10/10_4_5_summary.htm</a>.
<ul>
<li>If more than 10 studies are present, test for the small study effect with the Egger test for continuous outcomes or the Rucker test for binary outcomes (<a href="http://cran.r-project.org/web/packages/metasens/">CRAN</a> and PMIDs: <a href="http://pubmed.gov/17592831,19836925">17592831,19836925</a>).</li> 
<li>When less than 10 studies are present, study size of less than 50 or 1000 patients total (PMID: <a href="http://pubmed.gov/23616031">23616031</a>) or 100 per arm (PMID: <a href="http://pubmed.gov/20639294">20639294</a>) in most of all available studies may suggest small study effect.</li>
<li>Selective reporting risk if trial not registered. Selective reporting is common (<a href="http://pubmed.gov/23407296,26287998,19724045">23407296,26287998,19724045</a>). Trial registration, may lead to less favorable conclusions.PMID: <a href="http://pubmed.gov/26244868,22214754">26244868,22214754</a></li>
</ul>
</td>
</tr>
<tr>
<td>Rating up the evidence</td>
<td>GRADE recommends rating up the evidence if one of the following exist (PMID: <a href="http://pubmed.gov/21802902">21802902</a>). Note similarity to Bradford-Hill criteria (PMID <a href="http://pubmed.gov/14283879">14283879</a>):
<ul>
<li>"GRADE suggests considering rating up quality of evidence one level when methodologically rigorous observational studies show at least a two-fold reduction or increase in risk, and rating up two levels for at least a five-fold reduction or increase in risk"</li>
<li>Dose-response gradient is present</li>
<li>"All plausible confounders or biases would decrease an apparent treatment effect"</li>
<li>Rapidity of the response</li>
</ul>
</td>
</tr>
</tbody></table>

<div>&nbsp;</div>

<div>
<a name="sof"/>
<span style="font-weight:bold;font-size:130%">Summary of Findings</span>
<span style="font-weight:bold"> (Not part of PRISMA checklist)</span>
</div>
<div>&nbsp;</div>
<div>If pooled studies show significant benefit</div>
<ul><li>Summary of Finding Tables (SoF) are constructed as detailed in the Cochrane Handbook (<a href="http://handbook-5-1.cochrane.org/chapter_11/11_5_summary_of_findings_tables.htm">Chapter 11</a>) and by Guyatt et al (PMID: <a href="http://pubmed.gov/21195583">21195583</a>). SoF are currently produced with <a href="http://tech.cochrane.org/revman/gradepro">GRADEpro</a>.</li></ul>

<div>If pooled studies <i>do not</i> show significant benefit</div>
<ul><li>Results are summarized based on p-values using judical analogies developed by Diamond (PMID <a href="http://pubmed.gov/19506168">19506168</a>).</ul>
<table class="tg">
  <tr style="background-color:lightgray">
    <th>P values</th>
    <th>Judicial analogy</th>
  </tr>
  <tr>
    <td>P &lt; 0.05 in all studies</td>
    <td>“Beyond a reasonable doubt”</td>
  </tr>
  <tr>
    <td>P &lt; 0.05 in some studies</td>
    <td>“Clear and convincing evidence”</td>
  </tr>
  <tr>
    <td>P &lt; 0.5 in all studies</td>
    <td>“Preponderance of the evidence”</td>
  </tr>
  <tr>
    <td>P &lt; 0.5 in some studies</td>
    <td>“Reasonable suspicion”</td>
  </tr>
  <tr>
    <td>P &lt; 0.5 in no studies</td>
    <td>“Insufficient evidence”</td>
  </tr>
   <tr>
    <td colspan=2>Based on Diamond, 2009 (PMID <a href="http://pubmed.gov/19506168">19506168</a>)</td>
  </tr>
</table>

<div>&nbsp;</div>

<div>
<a name="reconciliation_tables"/>
<span style="font-weight:bold;font-size:130%">Reconciliation of Conclusions with prior meta-analyses</span>
<span style="font-weight:bold"> (Not part of PRISMA checklist)</span>
</div>
<div>The has been advocated (PMID <a href="http://pubmed.gov25551377">25551377</a>) and implemented (<a href="http://pubmed.gov/25796995">25796995</a>) previously.</div>

<div><a href="https://github.com/openMetaAnalysis/Early-goal-directed-therapy-for-septic-shock/blob/master/Reconciliation%20of%20conclusions.csv">Example table</a>.</div>

<div>&nbsp;</div>
<h3>References</h3>
<div>
<ol class="task-list">
<li><a href="http://handbook-5-1.cochrane.org/chapter_8/8_5_the_cochrane_collaborations_tool_for_assessing_risk_of_bias.htm">Risk of bias tool</a>. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from <a href="http://www.cochrane-handbook-5-1.org">http://www.cochrane-handbook-5-1.org</a></li>
<li><a href="http://handbook-5-1.cochrane.org/chapter_12/12_2_1_the_grade_approach.htm">The GRADE approach</a>. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from <a href="http://www.cochrane-handbook-5-1.org">http://www.cochrane-handbook-5-1.org</a></li>
<li>Schünemann H, Brożek J, Guyatt G, Oxman A (editors). <a href="http://www.guidelinedevelopment.org/handbook/">GRADE Handbook</a>. [updated October 2013]. Available from <a href="http://www.guidelinedevelopment.org/handbook/">http://www.guidelinedevelopment.org/handbook/</a></li>
<li><a href="http://handbook-5-1.cochrane.org/chapter_9/9_5_2_identifying_and_measuring_heterogeneity.htm">Identifying and measuring heterogeneity</a>. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from <a href="http://www.cochrane-handbook-5-1.org">http://www.cochrane-handbook-5-1.org</a></li>
</ol>
</div>

<div>Click here to see the <a href="https://github.com/openMetaAnalysis/home/pulse">revision history</a> of the source code.</div>
<div>&nbsp;</div>

<script>
//For gh-pages
//Page history and edit
var pagename = location.pathname.split('/').slice(-1);
if (pagename.toString().length < 1){pagename = "index.html"}
document.write("<div style='text-align:center'><a href='https://github.com/openMetaAnalysis/openMetaAnalysis.github.io/blob/master/" + pagename + "'>Edit this page</a> - <a href='https://github.com/openMetaAnalysis/openMetaAnalysis.github.io/commits/master/" + pagename + "'>Page history</a></div>")
</script>

</div>
    <script src="javascripts/scale.fix.js"></script>
              <script type="text/javascript">
            var gaJsHost = (("https:" == document.location.protocol) ? "https://ssl." : "http://www.");
            document.write(unescape("%3Cscript src='" + gaJsHost + "google-analytics.com/ga.js' type='text/javascript'%3E%3C/script%3E"));
          </script>
          <script type="text/javascript">
            try {
              var pageTracker = _gat._getTracker("UA-56740469-1");
            pageTracker._trackPageview();
            } catch(err) {}
          </script>
<div id="tip" style="display:none"></div>
</body>
</html>
